•  
  •  
  •  
  •  

2025-12-08 19:13:05

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Venus Remedies Marks Completion of AMR Licensing Milestones with Final Rs. 11 Crore Payment
  • Rishabh signs Euro 1mn contract with leading European Company
  • Nisus Finance's RESO-1 Delivers 23% IRR Exit from Special Situation Investment in Bengaluru
  • SEPC JV receives LoA for Bihta Airport
  • Adani Green Energy deepens nature-positive leadership with a global biodiversity disclosure framework

Keywords Selected:  LacosamideTablets

Stock Report

  • Zydus receives final approval from the USFDA for Lacosamide Tablets
  • Indoco Remedies receives USFDA approval for Lacosamide Tablets
  • Alembic Pharmaceuticals receives USFDA Final Approval for Lacosamide Tablets USP, 50 mg, 100 mg, 150 mg, and 200 mg
  • Glenmark Pharmaceuticals receives ANDA approval for Lacosamide Tablets USP, 50 mg, 100 mg, 150 mg and 200 mg

Latest Post

  • Venus Remedies Marks Completion of AMR Licensing Milestones with Final Rs. 11 Crore Payment
  • Rishabh signs Euro 1mn contract with leading European Company
  • Nisus Finance's RESO-1 Delivers 23% IRR Exit from Special Situation Investment in Bengaluru
  • SEPC JV receives LoA for Bihta Airport
  • Adani Green Energy deepens nature-positive leadership with a global biodiversity disclosure framework


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024